# Degarelix

## FIRMAGON inj 120mg/3mL

##### 臨採

| TAH Drug Code      | [IFIR](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IFIR)                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Advanced hormone-dependent prostate cancer in adult male patients.                                                                                                                                                                                                                                                        |
| Dosing             | Loading dose: 240 mg administered as two 120 mg (3 mL) injections; Maintenance dose: 80 mg administered as one 4 mL injection every 28 days (beginning 28 days after initial loading dose)                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                             |
| Contraindications  | Known hypersensitivity to degarelix or any component of the formulation; pregnant.                                                                                                                                                                                                                                        |
| Adverse Effects    | Hot flush, inj site reactions. Anemia; increased wt; insomnia; dizziness, headache, diarrhea, nausea; increased liver transaminases; hyperhidrosis (including night sweats), rash, musculoskeletal pain & discomfort; gynecomastia, testicular atrophy, erectile dysfunction; chills, pyrexia, fatigue, flu-like illness. |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                   |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/degarelix-drug-information)                                                                                                                                                                                                                                                  |

## Firmagon inj 80mg/4mL

| TAH Drug Code      | [IFIR8](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IFIR8)                                                                                                                                                                                                                                                    |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Advanced hormone-dependent prostate cancer in adult male patients.                                                                                                                                                                                                                                                        |
| Dosing             | Loading dose: 240 mg administered as two 120 mg (3 mL) injections; Maintenance dose: 80 mg administered as one 4 mL injection every 28 days (beginning 28 days after initial loading dose)                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                             |
| Contraindications  | Known hypersensitivity to degarelix or any component of the formulation; pregnant.                                                                                                                                                                                                                                        |
| Adverse Effects    | Hot flush, inj site reactions. Anemia; increased wt; insomnia; dizziness, headache, diarrhea, nausea; increased liver transaminases; hyperhidrosis (including night sweats), rash, musculoskeletal pain & discomfort; gynecomastia, testicular atrophy, erectile dysfunction; chills, pyrexia, fatigue, flu-like illness. |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                   |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/degarelix-drug-information)                                                                                                                                                                                                                                                  |

